Objectives: This study investigated the awareness and acceptance of digital therapeutics (DTx) among psychiatrists in South Korea, providing empirical insights to support future clinical implementation and dissemination. Methods: An online survey targeting 50 psychiatrists was conducted from October 2024 to February 2025. Descriptive statistics were performed on completed responses (n=36), focusing on DTx-related awareness and acceptance. Results: Most participants were aware of DTx, but few had experience prescribing it. They had positive expectations of increased treatment options and efficacy, with most information obtained through exhibitions and conferences. The key factors influencing the intention to use included reimbursement availability and the feasibility of integration with the electronic medical records. Many were motivated by interest in novel treatments and were willing to use DTx if peer adoption increased. The primary concern was uncertainty around reimbursement, and DTx was generally preferred as an adjunctive treatment. The appropriate cost for six sessions was considered to be 150000 KRW (approximately 110 USD) or less. The participants emphasized evidence-based effectiveness, convenience, and efficiency when promoting patient engagement. The need for incorporating DTx education into psychiatric residency training was also recognized. Conclusion This study is the first of its kind in South Korea to explore psychiatrists’ perspectives on DTx, offering foundational insights to help develop policy and education strategies for clinical and institutional implementation.